Non- Isolation Treatment of Atrial Fibrillation: Does Autonomic Nerve Modulation Really Act?

Hong-Tao Wang,Qiang-Sun Zheng,Xiong-Tao Liu,Jun Li,Fu-Jun Shang,Fei-Fei Su,Bo-yuan Fan,Dong-Bo Ou

DOI: https://doi.org/10.5772/25427

2012-01-11

Abstract:Non- Isolation Treatment of Atrial Fibrillation: Does Autonomic Nerve Modulation Really Act? | InTechOpen, Published on: 2012-01-11. Authors: Hong-Tao Wang, Qiang-Sun Zheng, Xiong-Tao Liu, et

What problem does this paper attempt to address?

Progress of cardiac autonomic nervous system and atrial fibrillation

WANG Zefeng,TAO Hailong,LI Ling

DOI: https://doi.org/10.13201/j.issn.1001-1439.2013.08.014

2013-01-01

Journal of Clinical Cardiology

Abstract:The role of the autonomic nervous system(ANS) in the genesis and/or in the maintenance of atrial fibrillation(AF) has been clinically recognized for many years.Vagal denervation enhances the efficacy of circumferential pulmonary vein ablation in preventing AF recurrence.Recent research showed that renal sympathetic denervation could also improve the efficacy of circumferential pulmonary vein ablation,and the role of ANS in AF therapy has become a hot topic.
Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Zhao-lian Ouyang,Li-ping Sun,Hui Chi,Ling Xia,Ying-lan Gong,Yu-bo Fan

DOI: https://doi.org/10.1007/s11596-018-1895-0

2018-01-01

Current Medical Science

Abstract:Two clinical ablation protocols, 2C3L and stepwise, have been routinely used in our group to treat atrial fibrillation (AF), but with a less than 60% long-term arrhythmia-free outcome achieved in patients. The goal of this study was to examine the underlying mechanism of low success in clinical outcome. MRI images from one patient were used to reconstruct a human atrial anatomical model, and fibrotic tissue was manually added to represent the arrhythmia substrate. AF was induced with standard protocols used in clinical practice. 2C3L and stepwise were then used to test the efficacy of arrhythmia termination in our model. The results showed that re-entries induced in our model could not be terminated by using either 2C3L or the stepwise protocol. Although some of the induced re-entries were terminated, others emerged in new areas. Ablation using only the 2C3L or stepwise method was not sufficient to terminate all re-entries in our model, which may partially explain the poor long-term arrhythmiafree outcomes in clinical practice. Our findings also suggest that computational heart modelling is an important tool to assist in the establishment of optimal ablation strategies.
Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation.

Xia Sheng,Benjamin J. Scherlag,Lilei Yu,Shuyan Li,Reza Ali,Ying Zhang,Guosheng Fu,Hiroshi Nakagawa,Warren M. Jackman,Ralph Lazzara,Sunny S. Po

DOI: https://doi.org/10.1016/j.jacc.2010.09.034

IF: 24

2011-01-01

Journal of the American College of Cardiology

Abstract:Objectives We hypothesized that autonomic atrial remodeling can be reversed by low-level (LL) vagosympathetic nerve stimulation (VNS).Background Previously, we showed that VNS can be antiarrhythmogenic.Methods Thirty-three dogs were subjected to electrical stimulation (20 Hz) applied to both vagosympathetic trunks at voltages 10% to 50% below the threshold that slowed sinus rate or AV conduction. Group 1 (n = 7): Programmed stimulation (PS) was performed at baseline and during 6-h rapid atrial pacing (RAP). PS allowed determination of effective refractory period (ERP) and AF inducibility measured by window of vulnerability (WOV). LL-VNS was continuously applied from the 4th to 6th hours. Group 2 (n = 4): After baseline ERP and WOV determinations, 6-h concomitant RAP+LL-VNS was applied. Sustained AF was induced by injecting acetylcholine (ACh) 10 mM into the anterior right ganglionated plexus (Group 3, n = 10) or applying ACh 10 mM to right atrial appendage (Group 4, n = 9).Results Group 1: The ERP progressively shortened and the Sigma WOV (sum of WOV from all tested sites) progressively increased (p < 0.05) during 3-h RAP then returned toward baseline during 3-h RAP+LL-VNS (p < 0.05). Group 2: 6-h concomitant RAP+LL-VNS did not induce any significant change in ERP and Sigma WOV. Group 3 and Group 4: AF duration (AF-D) and cycle length (AF-CL) were markedly altered by 3-h LL-VNS (Group 3: baseline: AF-D = 389 +/- 90 s, AF-CL = 45.1 +/- 7.8 ms; LL-VNS: AF-D = 50 +/- 15 s, AF-CL = 82.0 +/- 13.7 ms [ both p < 0.001]; Group 4: baseline: AF-D = 505 +/- 162 s, AF-CL = 48.8 +/- 6.6 ms; LL-VNS: AF-D = 71 +/- 21 s, AF-CL = 101.3 +/- 20.9 ms [ both p < 0.001]).Conclusions LL-VNS can prevent and reverse atrial remodeling induced by RAP as well as suppress AF induced by strong cholinergic stimulation. Inhibition of the intrinsic cardiac autonomic nervous system by LL-VNS may be responsible for these salutary results. (J Am Coll Cardiol 2011; 57: 563-71) (C) 2011 by the American College of Cardiology Foundation
Non-invasive Autonomic Neuromodulation Is Opening New Landscapes for Cardiovascular Diseases

Mingxian Chen,Songyun Wang,Xuping Li,Lilei Yu,Hui Yang,Qiming Liu,Jianjun Tang,Shenghua Zhou

DOI: https://doi.org/10.3389/fphys.2020.550578

IF: 4

2020-12-15

Frontiers in Physiology

Abstract:Autonomic imbalance plays a crucial role in the genesis and maintenance of cardiac disorders. Approaches to maintain sympatho-vagal balance in heart diseases have gained great interest in recent years. Emerging therapies However, certain types of emerging therapies including direct electrical stimulation and nerve denervation require invasive implantation of a generator and a bipolar electrode subcutaneously or result in autonomic nervous system (ANS) damage, inevitably increasing the risk of complications. More recently, non-invasive neuromodulation approaches have received great interest in ANS modulation. Non-invasive approaches have opened new fields in the treatment of cardiovascular diseases. Herein, we will review the protective roles of non-invasive neuromodulation techniques in heart diseases, including transcutaneous auricular vagus nerve stimulation, electromagnetic field stimulation, ultrasound stimulation, autonomic modulation in optogenetics, and light-emitting diode and transcutaneous cervical vagus nerve stimulation (gammaCore).

physiology
Development of neuromodulation for atrial fibrillation: a narrative review

Ning Yang,Yang Zou,Bohan Wen,Yingman Wang,Ju Mei,Zhaolei Jiang

DOI: https://doi.org/10.21037/jtd-23-1981

2024-05-31

Abstract:Background and objective: Atrial fibrillation (AF) is a prevalent clinical arrhythmia with a high incidence of disability and mortality. Autonomic nervous system (ANS) plays a crucial role in the onset and persistence of AF, and can lead to electrophysiological changes and alterations in atrial structure. Both animal models and clinical findings suggest that parasympathetic and sympathetic activity within the cardiac ANS could induce atrial remodeling and AF. Remodeling of the cardiac autonomic nerves is a significant structural basis for promoting AF. Given the challenges faced by conventional pharmacological and atrial ablation techniques in the treatment of AF, increasing attention has been paid to autonomic intervention strategies for AF. Current research has demonstrated that the frequency and severity of AF episodes can be significantly reduced by modulating the activity of ANS. ANS neuromodulation is expected to lead more effective and personalized treatment options for patients with AF. The objective of this review is to provide a broader perspective for future related studies by reviewing preclinical and clinical studies of neuromodulation methods for the treatment of AF, searching for relevant approaches to treat AF, as well as identifying the strengths and weaknesses demonstrated by current relevant studies, and providing researchers with a broader overview of the latest neurological treatments for AF. Methods: A narrative review was conducted on the literature on PubMed, WanFang data, and Google Scholar, including all relevant studies published until November 2023. Key content and findings: In this review, we delve into the innervation of cardiac autonomic nerves, the role of the ANS in the development and maintenance of AF, and the current neuromodulation methods for AF treatment. These methods include stellate ganglion (SG) resection or ablation, vagus nerve stimulation (VNS), thoracic subcutaneous nerve stimulation (ScNS), renal denervation (RDN) therapy, ganglionated plexus (GP) ablation, and epicardial botulinum toxin or CaCl2 injection. More and more research suggests that neuromodulation methods for the treatment of AF have broad prospects. Conclusions: ANS plays a crucial role in AF development and maintenance through cardiac autonomic nerve remodeling. Modulating ANS activity can significantly reduce AF frequency and severity, offering more personalized treatment options. Current research on autonomic interventions for AF shows promise for more effective and personalized treatments.
Anticancer activity of Scutellaria baicalensis and its potential mechanism.

F. Ye,Li Xui,Jizu Yi,Wandi Zhang,David Y. Zhang

DOI: https://doi.org/10.1089/107555302320825075

2002-10-01

Abstract:OBJECTIVE Scutellaria baicalensis is a widely used Chinese herbal medicine that historically is used in anti-inflammatory and anticancer therapy. The aim of the study is to determine its ability to inhibit human cancer cells in vitro and to determine whether its anticancer activity is because of the inhibition of prostaglandin E(2) (PGE(2)) production that is derived from arachidonic acid through cyclooxygenase-2 (COX-2) pathway. METHODS Cell lines from the most common human cancers, including squamous cell carcinoma (SCC-25, KB), breast cancer (MCF-7), hepatocellular carcinoma (HepG2), prostate carcinoma (PC-3 and LNCaP), and colon cancer (KM-12 and HCT-15) were tested. The cells were treated with various concentrations of Scutellaria baicalensis (0.1-100 mg/mL) for 72 hours. Percentage of viable cells after treatment was assessed using a trypan blue dye exclusion assay and the level of PGE(2) production was determined by enzyme immunoassay (EIA). RESULTS Scutellaria baicalensis demonstrated a strong dose-dependent growth inhibition in all cell lines. Inhibition concentration at 50% (IC(50)) for HepG2, MCF-7, PC-3, LNCaP, KM-12, HCT-15, KB and SCC-25 cells was 1.1, 0.9, 0.52, 0.82, 1.1, 1.5, 1.0, and 1.2 mg/mL, respectively. Three cell lines (KB, SCC-25, and HepG2) were assessed for the production of PGE(2) and a high level of extracellular (KB and SCC-25) and intracellular PGE(2) (HepG2) was noted. In the presence of Scutellaria baicalensis extract, there was a significant decrease of PGE(2) in a dose-dependent fashion. CONCLUSIONS Scutellaria baicalensis strongly inhibits cell growth in all cancer cell lines tested. However, prostate and breast cancer cells (PC-3, LNCaP, and MCF-7) are slightly more sensitive than other type of cancer cells. It also inhibits PGE(2) production, indicating that suppression of tumor cell growth may be due to its ability to inhibit COX-2 activity. This study supports the notion of using Scutellaria baicalensis as a novel anticancer agent to treat various cancers.
Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week

Stefanos Zafeiropoulos,Ioannis Doundoulakis,Ioannis T Farmakis,Santiago Miyara,Dimitrios Giannis,George Giannakoulas,Dimitris Tsiachris,Raman Mitra,Nicholas T Skipitaris,Stavros E Mountantonakis,Stavros Stavrakis,Stavros Zanos

DOI: https://doi.org/10.1016/j.jacc.2021.12.010

2022-02-22

Abstract:Autonomic neuromodulation therapies (ANMTs) (ie, ganglionated plexus ablation, epicardial injections for temporary neurotoxicity, low-level vagus nerve stimulation [LL-VNS], stellate ganglion block, baroreceptor stimulation, spinal cord stimulation, and renal nerve denervation) constitute an emerging therapeutic approach for arrhythmias. Very little is known about ANMTs' preventive potential for postoperative atrial fibrillation (POAF) after cardiac surgery. The purpose of this review is to summarize and critically appraise the currently available evidence. Herein, the authors conducted a systematic review of 922 articles that yielded 7 randomized controlled trials. In the meta-analysis, ANMTs reduced POAF incidence (OR: 0.37; 95% CI: 0.25 to 0.55) and burden (mean difference [MD]: -3.51 hours; 95% CI: -6.64 to -0.38 hours), length of stay (MD: -0.82 days; 95% CI: -1.59 to -0.04 days), and interleukin-6 (MD: -79.92 pg/mL; 95% CI: -151.12 to -8.33 pg/mL), mainly attributed to LL-VNS and epicardial injections. Moving forward, these findings establish a base for future larger and comparative trials with ANMTs, to optimize and expand their use.
Choosing rules to govern the commons: a model with evidence from Mexico ☆

J. Dayton-Johnson

DOI: https://doi.org/10.1016/S0167-2681(00)00073-1

2000-05-01

Abstract:
Autonomic Modulation by Electrical Stimulation of the Parasympathetic Nervous System: An Emerging Intervention for Cardiovascular Diseases

Bo He,Zhibing Lu,Wenbo He,Bing Huang,Hong Jiang

DOI: https://doi.org/10.1111/1755-5922.12179

Abstract:The cardiac autonomic nervous system has been known to play an important role in the development and progression of cardiovascular diseases. Autonomic modulation by electrical stimulation of the parasympathetic nervous system, which increases the parasympathetic activity and suppresses the sympathetic activity, is emerging as a therapeutic strategy for the treatment of cardiovascular diseases. Here, we review the recent literature on autonomic modulation by electrical stimulation of the parasympathetic nervous system, including vagus nerve stimulation, transcutaneous auricular vagal stimulation, spinal cord stimulation, and ganglionated plexi stimulation, in the treatment of heart failure, atrial fibrillation, and ventricular arrhythmias.
Transcutaneous Non-Invasive Vagus Nerve Stimulation: Changing the Paradigm for Stroke and Atrial Fibrillation Therapies?

Carola Y. Förster

DOI: https://doi.org/10.3390/biom14121511

IF: 6.064

2024-11-28

Biomolecules

Abstract:A new therapeutic approach, known as neuromodulation therapy—which encompasses a variety of interventional techniques meant to alter the nervous system in order to achieve therapeutic effects—has emerged in recent years as a result of advancements in neuroscience. Currently used methods for neuromodulation include direct and indirect approaches, as well as invasive and non-invasive interventions. For instance, the two primary methods of stimulating the vagus nerve (VN) are invasive VN stimulation (iVNS) and transcutaneous VN stimulation (tVNS). Since the latter is non-invasive, basic, clinical, and translational studies have focused on transcutaneous auricular VN stimulation (taVNS), the primary tVNS therapy, because of its advantages over iVNS, including ease of use, greater accessibility, and a lower side effect profile. taVNS is currently used as a novel neuromodulatory application to treat cardiovascular, mental, and autoimmune diseases. Future applications of this non-invasive neuromodulation technology to conditions like atrial fibrillation (AF) or ischemic stroke are highly likely due to its advancement.

biochemistry & molecular biology
Restoring the Autonomic Balance in an Atrial Fibrillation Rat Model by Electroacupuncture at the Neiguan Point

Yang Su,Jing Huang,Shengxuan Sun,Teng He,Taiyi Wang,Mengyue Fan,Huanhuan Yu,Jinglan Yan,Lin Yao,Yucen Xia,Meng Zhang,Yuanjia Zheng,Xiaoyan Luo,Yuewen Zhang,Manqi Lu,Meixia Zou,Cunzhi Liu,Yongjun Chen

DOI: https://doi.org/10.1016/j.neurom.2022.11.005

2022-12-01

Abstract:OBJECTIVES: Autonomic nervous activity imbalance plays an important role in atrial fibrillation (AF). AF can be treated by acupuncture at the Neiguan point (PC6), but the mechanism remains elusive. Here, we investigated autonomic nervous system activity in electroacupuncture (EA) at PC6 in a rat AF model.MATERIAL AND METHODS: In this study, we established a rat AF model via tail vein injection with ACh-CaCl<sub>2</sub> for ten consecutive days with or without EA at PC6. AF inducibility and heart rate variability (HRV) were assessed by electrocardiogram. Next, we completed in vivo recording of the activity of cervical sympathetic and vagal nerves, respectively. Finally, the activities of brain regions related to autonomic nerve regulation were assessed by c-Fos immunofluorescence and multichannel recording.RESULTS: EA at PC6 decreased AF inducibility and prevented changes in HRV caused by ACh-CaCl<sub>2</sub> injection. Meanwhile, EA at PC6 reversed the increased sympathetic and decreased vagal nerve activity in AF rats. Furthermore, EA treatment downregulated increased c-Fos expression in brain regions, including paraventricular nucleus, rostral ventrolateral medulla, and dorsal motor nucleus of the vagus in AF, while c-Fos expression in nucleus ambiguus was upregulated with EA.CONCLUSION: The protective effect of EA at PC6 on AF is associated with balance between sympathetic and vagal nerve activities.

medicine, research & experimental,clinical neurology
Neuromodulation for the Treatment of Heart Rhythm Disorders

Nathan H Waldron,Marat Fudim,Joseph P Mathew,Jonathan P Piccini

DOI: https://doi.org/10.1016/j.jacbts.2019.02.009

2019-08-26

Abstract:There is an increasing recognition of the importance of interactions between the heart and the autonomic nervous system in the pathophysiology of arrhythmias. These interactions play a role in both the initiation and maintenance of arrhythmias and are important in both atrial and ventricular arrhythmia. Given the importance of the autonomic nervous system in the pathophysiology of arrhythmias, there has been notable effort in the field to improve existing therapies and pioneer additional interventions directed at cardiac-autonomic targets. The interventions are targeted to multiple and different anatomic targets across the neurocardiac axis. The purpose of this review is to provide an overview of the rationale for neuromodulation in the treatment of arrhythmias and to review the specific treatments under evaluation and development for the treatment of both atrial fibrillation and ventricular arrhythmias.
Effect of sample treatment on biomechanical properties of insect cuticle.

B. Aberle,Raouf Jemmali,J. Dirks

DOI: https://doi.org/10.1016/j.asd.2016.08.001

IF: 2.075

Arthropod Structure & Development

Abstract:
Journal of The American Dietetic Association, Volume 45, 1964: Comparisons of siblings in Boston and Ireland: physical, biochemical, and dietary findings.

M. Trulson,R. E. Clancy,W. Jessop,R. Childers,F. Stare

DOI: https://doi.org/10.1111/j.1753-4887.1990.tb02881.x

2009-04-27

Nutrition Reviews

Abstract:This is a progress report of some of the findings of the Ireland-Boston Heart Study. The following observations have been made: Death rates from coronary heart disease are higher in the United States than in Ireland for men in the forty-five to sixty-five year age group. Statistical evidence suggests that there are differences in mortality rates from coronary artery disease in foreign-born, first-generation Americans, and American-born men (men both of whose parents were born in the United States). Irish Americans are heavier and fatter than are their brothers in Ireland. The levels of serum cholesterol are higher in Boston brothers than their counterparts in A high percentage of men in both groups smoke cigarettes. The American Irish had Recordings of blood pressure classified as hypertension were higher in the American The Boston men are less active physically than their brothers in Ireland. The Boston brother eats less than his Irish brother. The brothers in Ireland consumed more calories and had a higher percentage of fat coming from animal sources than did the Boston brothers. They consumed more starches (cereals and potatoes) than did their Boston brothers. Physical activity, way of life, and meal patterns differ between the Irish-born Americans and his brother living in Western Ireland. Ireland. more men smoking more than one package per day. Irish than in their brothers in Ireland.
Modulating activity of PVN neurons prevents atrial fibrillation induced circulation dysfunction by electroacupuncture at BL15

Jingya Wang,Qiumei Zhang,Lin Yao,Teng He,Xinyi Chen,Yang Su,Shengxuan Sun,Mengyue Fan,Jinglan Yan,Taiyi Wang,Meng Zhang,Feng Guo,Shiqing Mo,Manqi Lu,Meixia Zou,Liangjie Li,Qing Yuan,Huashan Pan,Yongjun Chen,Liangjie Li…

DOI: https://doi.org/10.1186/s13020-023-00841-6

IF: 4.546

2023-10-18

Chinese Medicine

Abstract:Circulation dysfunction is a major contributing factor to thrombosis in patients with atrial fibrillation (AF) for which effective interventions are lacking. Growing evidence indicates that regulating the paraventricular nucleus (PVN), an autonomic control center, could offer a novel strategy for treating cardiovascular and circulatory diseases. Concurrently, electroacupuncture (EA) at Xinshu (BL15), a form of peripheral nerve stimulation, has shown efficacy in treating several cardiovascular conditions, although its specific mechanism remains unclear. This study aimed to assess the impact of EA at BL15 on circulatory dysfunction in a rat AF model and investigate the pivotal role of PVN neuronal activity.

pharmacology & pharmacy,integrative & complementary medicine
Autonomic modulation of ventricular electrical activity: recent developments and clinical implications

Valerie Y. H. van Weperen,Marc A. Vos,Olujimi A. Ajijola

DOI: https://doi.org/10.1007/s10286-021-00823-4

2021-09-30

Clinical Autonomic Research

Abstract:Abstract Purpose This review aimed to provide a complete overview of the current stance and recent developments in antiarrhythmic neuromodulatory interventions, focusing on lifethreatening vetricular arrhythmias. Methods Both preclinical studies and clinical studies were assessed to highlight the gaps in knowledge that remain to be answered and the necessary steps required to properly translate these strategies to the clinical setting. Results Cardiac autonomic imbalance, characterized by chronic sympathoexcitation and parasympathetic withdrawal, destabilizes cardiac electrophysiology and promotes ventricular arrhythmogenesis. Therefore, neuromodulatory interventions that target the sympatho-vagal imbalance have emerged as promising antiarrhythmic strategies. These strategies are aimed at different parts of the cardiac neuraxis and directly or indirectly restore cardiac autonomic tone. These interventions include pharmacological blockade of sympathetic neurotransmitters and neuropeptides, cardiac sympathetic denervation, thoracic epidural anesthesia, and spinal cord and vagal nerve stimulation. Conclusion Neuromodulatory strategies have repeatedly been demonstrated to be highly effective and very promising anti-arrhythmic therapies. Nevertheless, there is still much room to gain in our understanding of neurocardiac physiology, refining the current neuromodulatory strategic options and elucidating the chronic effects of many of these strategic options.

neurosciences,clinical neurology
A New Hope for the Treatment of Atrial Fibrillation: Application of Pulsed-Field Ablation Technology

Zhen Wang,Ming Liang,Jingyang Sun,Jie Zhang,Yaling Han

DOI: https://doi.org/10.3390/jcdd11060175

2024-06-05

Abstract:In recent years, the prevalence of and mortality associated with cardiovascular diseases have been rising in most countries and regions. AF is the most common arrhythmic condition, and there are several treatment options for AF. Pulmonary vein isolation is an effective treatment for AF and is the cornerstone of current ablation techniques, which have one major limitation: even when diagnosed and treated at a facility that specializes in ablation, patients have a greater chance of recurrence. Therefore, there is a need to develop better ablation techniques for the treatment of AF. This article first compares the current cryoablation (CBA) and radiofrequency ablation (RFA) techniques for the treatment of AF and discusses the utility and advantages of the development of pulsed-field ablation (PFA) technology. The current research on PFA is summarized from three perspectives, namely, simulation experiments, animal experiments, and clinical studies. The results of different stages of experiments are summarized, especially during animal studies, where pulmonary vein isolation was carried out effectively without causing injury to the phrenic nerve, esophagus, and pulmonary veins, with higher safety and shorter incision times. This paper focuses on a review of various a priori and clinical studies of this new technique for the treatment of AF.
Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?

Zhihong Wu,Jiaying Liao,Qiming Liu,Shenghua Zhou,Mingxian Chen

DOI: https://doi.org/10.3389/fcvm.2023.1052471

IF: 3.6

2023-07-19

Frontiers in Cardiovascular Medicine

Abstract:Autonomic imbalance between the sympathetic and parasympathetic nervous systems contributes to the progression of chronic heart failure (HF). Preclinical studies have demonstrated that various neuromodulation strategies may exert beneficial cardioprotective effects in preclinical models of HF. Based on these encouraging experimental data, vagus nerve stimulation (VNS) has been assessed in patients with HF with a reduced ejection fraction. Nevertheless, the main trials conducted thus far have yielded conflicting findings, questioning the clinical efficacy of VNS in this context. This review will therefore focus on the role of the autonomic nervous system in HF pathophysiology and VNS therapy, highlighting the potential reasons behind the discrepancy between preclinical and clinical studies.

cardiac & cardiovascular systems
Detection of immune complexes in polymyositis

WilhelminaM.H Behan,T. Barkas,P. O. Behan

DOI: https://doi.org/10.1111/j.1600-0404.1982.tb03089.x

1982-04-01

Acta Neurologica Scandinavica

Abstract:There is good evidence to suggest a role for immunological factors in the pathogenesis of polymyositis although the exact mechanism and type of immunological disorder is unknown. The specific cellular and humoral hypersensitivity to muscle antigens described is most likely to represent an epiphenomenon.
Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure

Marvin A. Konstam,Douglas L. Mann,John James E. Udelson,Jeffrey L. Ardell,Gaetano M. De Ferrari,Martin R. Cowie,Helmut U. Klein,Douglas D. Gregory,Joseph M. Massaro,Imad Libbus,Lorenzo A. DiCarlo,Javed Butler,John D. Parker,John R. Teerlink

DOI: https://doi.org/10.3389/fphys.2022.857538

IF: 4

2022-04-22

Frontiers in Physiology

Abstract:The ANTHEM-HF, INOVATE-HF, and NECTAR-HF clinical studies of autonomic regulation therapy (ART) using vagus nerve stimulation (VNS) systems have collectively provided dose-ranging information enabling the development of several working hypotheses on how stimulation frequency can be utilized during VNS for tolerability and improving cardiovascular outcomes in patients living with heart failure (HF) and reduced ejection fraction (HFrEF). Changes in heart rate dynamics, comprising reduced heart rate (HR) and increased HR variability, are a biomarker of autonomic nerve system engagement and cardiac control, and appear to be sensitive to VNS that is delivered using a stimulation frequency that is similar to the natural operating frequency of the vagus nerve. Among prior studies, the ANTHEM-HF Pilot Study has provided the clearest evidence of autonomic engagement with VNS that was delivered using a stimulation frequency that was within the operating range of the vagus nerve. Achieving autonomic engagement was accompanied by improvement from baseline in six-minute walk duration (6MWD), health-related quality of life, and left ventricular EF (LVEF), over and above those achieved by concomitant guideline-directed medical therapy (GDMT) administered to counteract harmful neurohormonal activation, with relative freedom from deleterious effects. Autonomic engagement and positive directional changes have persisted over time, and an exploratory analysis suggests that improvement in autonomic tone, symptoms, and physical capacity may be independent of baseline NT-proBNP values. Based upon these encouraging observations, prospective, randomized controlled trials examining the effects on symptoms and cardiac function as well as natural history have been warranted. A multi-national, large-scale, randomized, controlled trial is well underway to determine the outcomes associated with ART using autonomic nervous system engagement as a guide for VNS delivery.

physiology

Non- Isolation Treatment of Atrial Fibrillation: Does Autonomic Nerve Modulation Really Act?

Progress of cardiac autonomic nervous system and atrial fibrillation

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation.

Non-invasive Autonomic Neuromodulation Is Opening New Landscapes for Cardiovascular Diseases

Development of neuromodulation for atrial fibrillation: a narrative review

Anticancer activity of Scutellaria baicalensis and its potential mechanism.

Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week

Choosing rules to govern the commons: a model with evidence from Mexico ☆

Autonomic Modulation by Electrical Stimulation of the Parasympathetic Nervous System: An Emerging Intervention for Cardiovascular Diseases

Transcutaneous Non-Invasive Vagus Nerve Stimulation: Changing the Paradigm for Stroke and Atrial Fibrillation Therapies?

Restoring the Autonomic Balance in an Atrial Fibrillation Rat Model by Electroacupuncture at the Neiguan Point

Neuromodulation for the Treatment of Heart Rhythm Disorders

Effect of sample treatment on biomechanical properties of insect cuticle.

Journal of The American Dietetic Association, Volume 45, 1964: Comparisons of siblings in Boston and Ireland: physical, biochemical, and dietary findings.

Modulating activity of PVN neurons prevents atrial fibrillation induced circulation dysfunction by electroacupuncture at BL15

Autonomic modulation of ventricular electrical activity: recent developments and clinical implications

A New Hope for the Treatment of Atrial Fibrillation: Application of Pulsed-Field Ablation Technology

Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?

Detection of immune complexes in polymyositis

Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure